Home Investors News Press Releases 2006

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

12/13/2006	Cyclacel submits IND of CYC116 an Aurora kinase and VEGRF2 inhibitor to treat cancer
12/06/2006	Cyclacel Pharmaceuticals to present at NYSSA 10th annual Biotech/Speciality Pharma Industry Conference
11/28/2006	Cyclacel reports interim Phase I data for sapacitabine in patients with advanced leukemias or myelodysplastic syndromes
11/17/2006	Cyclacel Pharmaceuticals to present at Lazard Capital Markets Life Sciences Conference
11/13/2006	Cyclacel Pharmaceuticals reports third quarter 2006 financial results
11/10/2006	Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting
11/06/2006	Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006
10/30/2006	Cyclacel Pharmaceuticals to present at Rodman & Renshaw annual healthcare conference
10/24/2006	Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development
10/24/2006	Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference
1  2  3    >>

  Go to top      Print page